Effective Cancer Targeting Using an Anti-tumor Tissue Vascular Endotheliumspecific Monoclonal Antibody (TES-23)
Open Access
- 1 December 2000
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 91 (12) , 1319-1325
- https://doi.org/10.1111/j.1349-7006.2000.tb00920.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Tumor Vascular Targeting Using a Tumor-Tissue Endothelium-Specific Monoclonal Antibody as an Effective Strategy for Cancer ChemotherapyBiochemical and Biophysical Research Communications, 1999
- Pharmacologic Modification of Tumor Blood Flow and Interstitial Fluid Pressure in a Human Tumor Xenograft: Network Analysis and Mechanistic InterpretationMicrovascular Research, 1995
- Tumor-conditioned medium increases macromolecular permeability of endothelial cell monolayerCancer Letters, 1995
- Isolation and Properties of Tumor-derived Endothelial Cells from Rat KMT-17 FibrosarcomaJapanese Journal of Cancer Research, 1995
- Vascular targeting—a new approach to the therapy of solid tumorsPharmacology & Therapeutics, 1994
- Microvascular Permeability of Albumin, Vascular Surface Area, and Vascular Volume Measured in Human Adenocarcinoma LS174T Using Dorsal Chamber in SCID MiceMicrovascular Research, 1993
- Penetration of Tumor Tissue by Antibodies and Other ImmunoproteinsAnnals of the New York Academy of Sciences, 1991
- The Identification of Proliferation-related Proteins in Human Endothelial Cells as a Possible Target in Tumour TherapyInternational Journal of Radiation Biology, 1991
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.The Journal of Experimental Medicine, 1986
- An improved Iodogen method of labelling antibodies with 123INuclear Medicine Communications, 1986